Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Solta Medical, Inc. Stockholders

Kirby McInerney LLP is investigating potential claims against the Board of Directors of Solta Medical, Inc. (“Solta” or the “Company”) (NASDAQ:SLTM) concerning the proposed acquisition of the Company by Valeant Pharmaceuticals International, Inc. (“Valeant”) (NYSE:VRX). Under the terms of the definitive merger agreement, Solta stockholders will receive $2.92 in cash for each share of Solta owned, valuing the transaction at approximately $250 million.

The investigation concerns whether the Solta Board of Directors violated its fiduciary duties by agreeing to the proposed transaction and whether the $2.92 per share proposed consideration adequately values Solta’s common stock.

If you are a Solta stockholder and wish to obtain additional information, please contact J. Brandon Walker, Esq. by email at [e-mail], by telephone at [phone] or [phone], or by filling out this contact form. There is no cost or obligation to you.

Kirby McInerney LLP is a New York-based law firm concentrating in securities, shareholder, whistleblower, antitrust and consumer litigation. For additional information, please go to www.kmllp.com.

Kirby McInerney LLPJ. Brandon Walker, Esq., [e-mail]